Halotop-F Cream is a topical formulation combining Halobetasol propionate (0.05% w/w), a potent corticosteroid, with Fusidic Acid (2% w/w), a bacteriostatic antibiotic. This combination is indicated for the treatment of inflammatory dermatoses complicated by secondary bacterial infections, such as eczema, psoriasis, and dermatitis. Halobetasol exerts strong anti-inflammatory, antipruritic, and vasoconstrictive effects by inhibiting multiple inflammatory cytokines and mediators, thereby reducing redness, swelling, and itching. Fusidic Acid targets gram-positive bacteria, particularly Staphylococcus aureus, by inhibiting bacterial protein synthesis, thus preventing or treating bacterial superinfection. Halotop-F Cream should be applied in a thin layer to the affected area once or twice daily, as directed by a healthcare professional, and treatment duration should not exceed two weeks to minimize the risk of adverse effects. Common side effects may include local burning, itching, or irritation. Prolonged use or application over large areas may lead to systemic corticosteroid absorption, causing hypothalamic-pituitary-adrenal axis suppression. Contraindications include viral, fungal, or tubercular skin infections. Caution is advised in pediatric and elderly patients. Halotop-F Cream offers an effective dual-action approach for managing inflammatory skin conditions with secondary bacterial involvement.